![James Kinley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 95 004 $ in data 31/05/2026
James F.
Kinley is currently Independent Director at Medicure, Inc. since 2022, Independent Director at Waverley Pharma, Inc. since 2024, Chief Financial Officer at Cytophage Technologies Ltd. starting 2026, Chief Financial Officer & Secretary at Grey Matters Health, Inc. since 2022, and Chief Financial Officer at Algernon Neuroscience, Inc. Formerly, Mr. Kinley was Principal at Ernst & Young LLP, Chief Financial Officer at Medicure, Inc. from 2011 to 2021, Manager at Manitoba Telecom Services, Inc., and Chief Financial Officer at Luminor Medical Technologies, Inc. from 2011 to 2016.
Education includes undergraduate studies at Asper School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/12/2025 | 178.992 ( 3,3% ) | 56 740 $ | 31/05/2026 | |
MEDICURE INC. 0,45% | 02/04/2026 | 47.100 ( 0,45% ) | 37 868 $ | 31/05/2026 |
| 05/05/2025 | 56.500 ( 0,1% ) | 396 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GREY MATTERS HEALTH INC. | Direttore Finanziario/CFO | 01/12/2021 |
| MEDICURE INC. | Direttore/Membro del Consiglio | 16/06/2022 |
| WAVERLEY PHARMA INC. | Direttore/Membro del Consiglio | 20/06/2024 |
| CYTOPHAGE TECHNOLOGIES LTD. | Direttore Finanziario/CFO | 20/01/2026 |
Algernon Neuroscience, Inc. | Direttore Finanziario/CFO | - |
| Società | Posizione | Fine |
|---|---|---|
| MEDICURE INC. | Direttore Finanziario/CFO | 15/05/2021 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Direttore Finanziario/CFO | 18/01/2016 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
| BELL MTS | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Medicure, Inc.
 Medicure, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research, development and commercialization & marketing of human therapeutics products | Health Technology |
Manitoba Telecom Services, Inc.
 Manitoba Telecom Services, Inc. Wireless TelecommunicationsCommunications Provides telecommunications services | Communications |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Asper School of Business
 Asper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algernon Pharmaceuticals, Inc.
 Algernon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage, drug development and repurposing company | Health Technology |
Waverley Pharma, Inc.
 Waverley Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Algernon Neuroscience, Inc. | |
Cytophage Technologies Ltd.
 Cytophage Technologies Ltd. Financial ConglomeratesFinance Produces bacteriophages for bacterial infections and diseases | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
